Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate

Annals of General Hospital Psychiatry

Volumn 3, Issue , 2004, Pages

  Wu, Ren H ^a   O'Donnell, Tina ^a   Ulrich, Michelle ^a   Asghar, Sheila J ^a   Hanstock, Christopher C ^a   Silverstone, Peter H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bipolar disorder; Choline; Lithium; Magnetic resonance spectroscopy; Sodium valproate

Indexed keywords

CHOLINE; CREATININE; LITHIUM; VALPROIC ACID;

ACETYLCHOLINE BRAIN LEVEL; ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FRONTAL LOBE; HUMAN; INTERMETHOD COMPARISON; MALE; METHODOLOGY; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE;

EID: 33846402816     PISSN: 14752832     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1475-2832-3-13     Document Type: Article

References (43)

1. Vestergaard P, Licht RW: 50 Years with lithium treatment in affective disorders: present problems and priorities. World J Biol Psychiatry 2001, 2: 18-26.
2. Lingsch C, Martin K: An irreversible effect of lithium administration to patients. Br J Pharmacol 1976, 57: 323-7.
3. Uney JB, Marchbanks RM, Reynolds GP, Perry RH: Lithium prophylaxis inhibits choline transport in post-mortem brain. Lancet 1986, 2(Aug 23): 458.
4. Jope RS, Jenden DJ, Ehrlich BE, Diamond JM: Choline accumulates in erythrocytes during lithium therapy. N Engl J Med 1978, 299: 833-834.
5. Brinkman SD, Pomara N, Barnett N, Block R, Domino EF, Gershon S: Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia. Biol Psychiatry 1984, 19: 157-64.
6. Domino EF, Sharp RR, Lipper S, Ballast CL, Delidow B, Bronzo MR: NMR chemistry analysis of red blood cell constituents in normal subjects and lithium-treated psychiatric patients. Biol Psychiatry 1985, 20: 1277-1283.
7. Stoll AL, Cohen BM, Hanin I: Erythrocyte choline concentrations in psychiatric disorders. Biol Psychiatry 1991, 29: 309-321.
8. Sartorius A, Neumann-Haefelin C, Bollmayr B, Hoehn M, Henn FA: Choline rise in the rat hippocampus induced by electroconvulsive shock treatment. Biol Psychiat 2003, 53: 620-623.
9. Leiva DB: The neurochemistry of mania: a hypothesis of etiology and rationale for treatment. Prog Neuropsychopharmacol Biol Psychiatry 1990, 14: 423-9.
10. Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF: Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiat 1996, 40: 382-8.
11. Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM: Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiat 1995, 37: 170-4.
12. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM: Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA 1995, 274: 902-7.
13. Deicken RF, Eliaz Y, Feiwell R, Schuff N: Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res 2001, 106: 35-45.
14. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, McCracken J: Decreased anterior cingulated myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24: 359-369.
15. Moore CM, Breeze JL, Gruber SA, Babb SM, deB Frederick B, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF: Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000, 2: 207-216.
16. Hamakawa H, Kato T, Murashita J, Kato N: Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998, 248: 53-58.
17. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, Inubushi T: Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996, 21: 248-254.
18. Sharma R, Venkatasubramanian PN, Barany M, Davis JM: Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 1992, 8: 43-49.
19. Deicken RF, Pegues MP, Anzalone S, Feiwell R, Soher B: Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiat 2003, 160: 873-882.
20. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR: Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiat 2003, 53: 906-913.
21. Chang K, Adleman N, Dienes K, Barnea-Goraly N, Reiss A, Ketter T: Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiat 2003, 53: 1059-1065.
22. Lyoo IK, Demopulos CM, Hirashima F, Ahn KW, Renshaw PF: Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. Bipolar Disord 2003, 5: 300-306.
23. Davanzo P, Yue K, Thomas MA, Belin T, Mintz J, Venkatraman TN, Santoro E, Barnett S, McCracken J: Proton magnetic spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 2003, 160:.
24. Castillo M, Kwock L, Courvoisie H, Hooper SR: Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. Am J Neuroradiol 2000, 21: 832-838.
25. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N: Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychological Med 1999, 29: 639-644.
26. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, Igarashi Y, Ohara K: Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psych Res Neuroimag Sect 1998, 84: 55-60.
27. Bruhn H, Stoppe G, Staedt J, Merboldt KD, Hänicke W, Frahm J: Quantitative proton MRS in vivo shows cerebral myo-inositol and cholines to be unchanged in manic-depressive patients treated with lithium [abstract]. Proc Soc Mag Res Med 1993:1543.
28. Cecil KM, DelBello MP, Morey R, Strakowski SM: Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Dis 2002, 4: 357-365.
29. Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, Lafer B, Gonzalez RG: The human brain resonance of cholinecontaining compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1992, 32: 944-949.
30. Silverstone PH, Hanstock CC, Rotzinger S: Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci 1999,24:222-226.
31. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM: Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry 2000, 48:505-517.
32. Strakowski SM, DelBello MP, Adler C, Cecil KM, Saz KW: Neuroimaging in bipolar disorder. Bipolar Disord 2000,2: 148-164.
33. Pies R: Combining lithium and anticonvulsants in bipolar disorder: a review. Ann Clin Psychiatry 2002, 14: 223-232.
34. Sher PK, Neale EA, Graubard BI, Habig WH, Fitzgerald SC, Nelson PG: Differential neurochemical effects of chronic exposure of cerebral cortical cell culture to valproic acid, diazepam, or ethosuximide. Pediatr Neurol 1985, 1: 232-7.
35. Moore CM, Breeze JL, Gruber SA, Babb SM, deB Frederick B, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF: Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000, 2: 207-216.
36. Simister RJ, McLean MA, Barker GJ, Duncan JS: Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003, 61: 897-902.
37. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH: Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Research 2000, 880: 84-91.
38. Silverstone PH, Asghar SJ, O'Donnell T, Ulrich M, Hanstock CC: Lithium protects against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. World J Biol Psychiat 2004, 5: 35-41.
39. Gordon RE, Ordidge RJ: Volume selection for high resolution NMR studies [abstract]. Proc Soc Magn Reson Med 1984:272.
40. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987, 508: 333-348.
41. Talairach J, Tournoux P: Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical 1988: 51-110.
42. 1H MRS study. Am J Psychiatry 1999, 156: 1879-1886.
43. Vermathen P, Capizzano AA, Maudsley AA: Administration and (1)H MRS detection of histidine in human brain: application to in vivo pH measurement. Magn Reson Med 2000, 43: 665-675.